Spain Cancer Supportive Care Drugs Market Size & Outlook
Spain cancer supportive care drugs market, 2018-2030 (US$M)
Related Markets
Spain cancer supportive care drugs market highlights
- The Spain cancer supportive care drugs market generated a revenue of USD 399.2 million in 2023 and is expected to reach USD 362.0 million by 2030.
- The Spain market is expected to grow at a CAGR of -1.4% from 2024 to 2030.
- In terms of segment, opioids was the largest revenue generating therapeutic class in 2023.
- NSAIDs and Others is the most lucrative therapeutic class segment registering the fastest growth during the forecast period.
Cancer supportive care drugs market data book summary
| Market revenue in 2023 | USD 399.2 million |
| Market revenue in 2030 | USD 362.0 million |
| Growth rate | -1.4% (CAGR from 2023 to 2030) |
| Largest segment | Opioids |
| Fastest growing segment | NSAIDs and Others |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Antiemetics, Bisphosphonates, Opioids, NSAIDs and Others |
| Key market players worldwide | Amgen Inc, Merck & Co Inc, Johnson & Johnson, Heron Therapeutics Inc, Novartis AG ADR, GSK PLC, Roche Holding AG ADR, Helsinn Healthcare |
Other key industry trends
- In terms of revenue, Spain accounted for 3.0% of the global cancer supportive care drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany cancer supportive care drugs market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 305.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Supportive Care Drugs Market Scope
Cancer Supportive Care Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain cancer supportive care drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer supportive care drugs market will help companies and investors design strategic landscapes.
Opioids was the largest segment with a revenue share of 25.98% in 2023. Horizon Databook has segmented the Spain cancer supportive care drugs market based on g-csfs (granulocyte-colony stimulating factors), esas (erythropoiesis stimulating agents), antiemetics, bisphosphonates, opioids, nsaids and others covering the revenue growth of each sub-segment from 2018 to 2030.
The country has a universal healthcare system that provides care to all the people, including foreigners working in the country. The adoption of advanced cancer therapeutic options is comparatively low in the country. Radiotherapy and chemotherapy are commonly prescribed options. These require additional supportive care drugs and services to mitigate adverse effects. Amgen Inc., Merck & Co. Inc., and GSK, are some of the key players currently operating in cancer supportive care drugs market in Spain.
The incidence of cancer is growing in Spain, primarily driven by rising geriatric population and high tobacco & alcohol consumption, particularly by men. As per International Agency for Research on Cancer, there were 282,000 new cases of cancer in 2020, led by prostate cancer and breast cancer in men & women, respectively. Moreover, the incidence of cancer is expected to increase further by ~17% to reach 330,000 cases by 2030.
According to a study, the prevalence of pain in advanced stage cancer patients is around 70%- 90%. Opioids and non-opioid analgesics are used for treatment of cancer pain. These factors are leading to moderate growth of the market. For patients experiencing CINV, NK1RA-based regimens are most commonly prescribed.
Reasons to subscribe to Spain cancer supportive care drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain cancer supportive care drugs market databook
-
Our clientele includes a mix of cancer supportive care drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain cancer supportive care drugs market , including forecasts for subscribers. This country databook contains high-level insights into Spain cancer supportive care drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain cancer supportive care drugs market size, by therapeutic class, 2018-2030 (US$M)
Spain Cancer Supportive Care Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
